The median time from CL56 to starting hormone therapy was greater in those who subsequently responded to hormones again although this did not reach statistical significance (8.0 vs 3.8 months, P =0.085).
← all excerpts
Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected finding.
1
0.0850
0.0850